1. Safety observation of COVID-19 inactivated vaccine in immature mice.
- Author
-
Zhou, Jingxuan, Han, Yingyan, Huang, Xiaoyuan, Zhang, Zhegang, Zhang, Jiayou, and Ji, Teng
- Abstract
AbstractObjectiveMethodsResultsConclusionTo investigate the safety of COVID-19 inactivated vaccine in immature mice.We selected 3-week-old immature BALB/c mice, continuously observed until 7 weeks old after continuous immunization with fully inactivated vaccine (initial strengthening), and sacrificed BALB/c mice at 7 weeks old, and used H&E, Masson, mast cells and Ki-67 staining to analyze the changes of heart, liver, spleen, kidney, lung and brain. In addition, RNA was extracted from important organs such as the heart, liver, spleen, kidney, lung, and brain, and to evaluate whether there was any effect after vaccination through bulk-RNA sequencing.After H&E, Masson, mast cells and Ki-67 staining analyses, there are no significant differences between tissues and organs in the vaccine group and the PBS group, and RNA-Seq did not show that the vaccine had any effect on immature mice.COVID-19 inactivated vaccine is safe in immature mice. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF